SIREN : 833558000
MEDITRANS is a French company founded 8 years ago, specialized in the sector Transports routiers de fret interurbains. Based in VITROLLES (13127), this company of category PME shows in 2025 a revenue of 5.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 5 351 662 € | 5 804 390 € | N/C | 5 933 023 € | N/C | N/C | N/C |
| Net income | 133 127 € | 357 605 € | 481 770 € | 569 172 € | 288 894 € | 269 528 € | -1 116 152 € |
| EBITDA | 236 893 € | 454 927 € | N/C | 632 503 € | N/C | N/C | N/C |
| Net margin | 2.5% | 6.2% | N/C | 9.6% | N/C | N/C | N/C |
In 2025, MEDITRANS achieves revenue of 5.4 M€. Activity remains stable over the period (CAGR: -3.4%). Slight decline of -8% vs 2024. After deducting consumption (0 €), gross margin stands at 5.4 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 237 k€, representing 4.4% of revenue. Warning negative scissor effect: despite revenue change (-8%), EBITDA varies by -48%, reducing margin by 3.4 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 133 k€, i.e. 2.5% of revenue. This profit can be retained or distributed to shareholders.
5 351 662 €
5 351 662 €
236 893 €
172 198 €
133 127 €
4.4%
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 3.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
0.78%
49.429%
3.635%
0.06
76.1%
In 2025, the debt ratio of MEDITRANS (0.78) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2025, the financial autonomy of MEDITRANS (49.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2025, the repayment capacity of MEDITRANS (0.06) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 191.71. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.9x. Coverage is limited: any activity downturn would jeopardize interest payments.
191.711
1.875
In 2025, the liquidity ratio of MEDITRANS (191.71) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2025, the interest coverage of MEDITRANS (1.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 62 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 69 days. Favorable situation: supplier credit is longer than customer credit by 7 days. Overall, WCR represents 70 days of revenue, i.e. 1.0 M€ to permanently finance.
1 042 129 €
62 j
69 j
0 j
70 j
Indicative estimate only : the number of comparable transactions in this sector is limited (41 transactions). This range of 307 064€ to 1 561 323€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 41 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MEDITRANS with other companies in the same sector:
Voir toutes les statistiques du secteur Transports routiers de fret interurbains
The revenue of MEDITRANS in 2025 is 5.4 M€.
Yes, MEDITRANS generated a net profit of 133 k€ in 2025.
The headquarters of MEDITRANS is located in VITROLLES (13127), in the department Bouches-du-Rhone.
The tax return of MEDITRANS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MEDITRANS operates in the sector Transports routiers de fret interurbains (NAF code 49.41A). See the 'Sector positioning' section above to compare the company with its competitors.